Viewing Study NCT01294202


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2025-12-26 @ 2:42 AM
Study NCT ID: NCT01294202
Status: COMPLETED
Last Update Posted: 2024-08-02
First Post: 2011-02-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST
Sponsor: Astex Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-03
Start Date Type: None
Primary Completion Date: 2013-04
Primary Completion Date Type: ACTUAL
Completion Date: 2014-07
Completion Date Type: ACTUAL
First Submit Date: 2011-02-10
First Submit QC Date: None
Study First Post Date: 2011-02-11
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2016-02-05
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2024-08-01
Last Update Post Date: 2024-08-02
Last Update Post Date Type: ACTUAL